Randox Cocaine Metabolite
Enzyme Immunoassay, Cocaine And Cocaine Metabolites. 510(k) K113751, from Randox Laboratories, Ltd. (Crumlin, GB). Product code DIO, class 2.
As of Nov 18, 2026, K113751 is an FDA 510(k) held by Randox Laboratories, Ltd., substantially equivalent on May 8, 2012 after 139 days, with no recalls tied to it in FDA's recall database.
- Review time: 139 days
- Recalls: 0
- Cited as a predicate by: 1 device
Cited as a predicate
1 later 510(k) summary names this device as a predicate- Immunalysis Benzoylecgonine Urine Enzyme Immunoassay, Immunalysis Benzoylecgonine Urine Calibrators, Immunalysis…K150925 · Immunalysis Corporation · Jun 29, 2015
Other DIO clearances
The newest 510(k)s for the same product code; see every DIO device- Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemK213211 · Carolina Liquid Chemistries Corp. · Jan 27, 2022
- DRI Cocaine Metabolite AssayK211973 · Microgenics Corporation · Sep 24, 2021
Record
- Type
- Traditional
- Received
- Dec 21, 2011
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files